TheraRadar
← Back
Data updated: Mar 29, 2026

NEPHRON

CardiovascularRespiratory
Generics

NEPHRON is a generic drug manufacturer focused on Cardiovascular, Respiratory.

1981
Since
11
Drugs
-
Trials
72
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

IPRATROPIUM BROMIDE 2026-02-23
BUDESONIDE 2026-01-26
Labeling
KETOROLAC TROMETHAMINE 2026-01-22
Labeling
ALBUTEROL SULFATE 2025-12-01
VERAPAMIL HYDROCHLORIDE 2025-11-24
ALBUTEROL SULFATE 2025-11-21
Labeling
VERAPAMIL HYDROCHLORIDE 2025-11-13
VERAPAMIL HYDROCHLORIDE 2025-09-19
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 75%
1 drugs
Respiratory 25%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Respiratory
AstraZeneca big-pharma
Respiratory, Cardiovascular
Boehringer Ingelheim big-pharma
Respiratory, Cardiovascular
GE HEALTHCARE specialty
Cardiovascular, Respiratory
BRACCO specialty
Cardiovascular, Respiratory